Page 248 - IJB-10-1
P. 248

International Journal of Bioprinting                             NIR-secretome release for nerve regeneration




            22.  Crock HV, Crock HV. The management of spinal injuries   34.  Carvalho M, Teixeira F, Reis R, Sousa N, Salgado AJ.
               with and without neural damage.  Pract Spinal Surg.    Mesenchymal stem cells in the umbilical cord: phenotypic
               1983;281-298.                                      characterization, secretome and applications in central
               doi: 10.1007/978-3-7091-3335-4_12                  nervous system regenerative medicine.  Curr Stem Cell Res
                                                                  Ther. 2011;6(3):221-228.
            23.  Bechstein WO. Neurotoxicity of calcineurin inhibitors: Impact      doi: 10.2174/157488811796575332
               and clinical management. Transpl Int. 2000;13(5):313-326.
               doi: 10.1007/s001470050708                      35.  Martins LF, Costa RO, Pedro JR, et al. Mesenchymal stem
                                                                  cells  secretome-induced axonal outgrowth is  mediated  by
            24.  Yamakami I, Yamaura A, Isobe K. Pathogenesis and
               management of secondary neural damage in head trauma   BDNF. Sci Rep. 2017;7(1):4153.
               patients: Analysis of patients who talk and deteriorate”      doi: 10.1038/s41598-017-03592-1
               fulminantly”. No Shinkei Geka. 1993;21(2):129-133.  36.  Teixeira FG, Salgado AJ. Mesenchymal stem cells secretome:
               doi: 10.11477/mf.1436900598                        Current trends and future challenges.  Neural Regen Res.
                                                                  2020;15(1):75.
            25.  Bejargafshe MJ, Hedayati M, Zahabiasli S, Nejad-Moghaddam      doi: 10.4103/1673-5374.264455
               A. Safety and efficacy of stem cell therapy for treatment of
               neural damage in patients with multiple sclerosis. Stem Cell    37.  Kumar P, Kandoi S, Misra R, S V, K R, Verma RS. The
               Investig. 2019;6:44.                               mesenchymal stem cell secretome: A new paradigm towards
               doi: 10.21037/sci.2019.10.06                       cell-free  therapeutic  mode  in  regenerative  medicine.
                                                                  Cytokine Growth Factor Rev. 2019;46:1-9.
            26.  Wong AM, Hodges H, Horsburgh K. Neural stem cell grafts
               reduce the extent of neuronal damage in a mouse model of      doi: 10.1016/j.cytogfr.2019.04.002
               global ischaemia. Brain Res. 2005;1063(2):140-150.  38.  Li  F, Zhang  J, Yi  K,  Wang H,  et  al.  Delivery  of stem cell
               doi: 10.1016/j.brainres.2005.09.049                secretome for therapeutic applications. ACS Appl Bio Mater.
                                                                  2022;5(5):2009-2030.
            27.  Karl  MO. The potential  of stem  cell  research  for  the      doi: 10.1021/acsabm.1c01312
               treatment of neuronal damage in glaucoma. Cell Tissue Res.
               2013;353(2):311-325.                            39.  Wechsler ME, Rao VV, Borelli AN, Anseth KS. Engineering
               doi: 10.1007/s00441-013-1646-2                     the MSC secretome: A hydrogel focused approach.
                                                                  Adv Healthc Mater. 2021;10(7):2001948.
            28.  Qin J, Ma X, Qi HH, et al. Transplantation of induced      doi: 10.1002/adhm.202001948
               pluripotent  stem  cells  alleviates  cerebral  inflammation
               and neural damage in hemorrhagic stroke.  PLoS One.   40.  Santamaria G, Brandi E, Vitola P La, et al. Intranasal delivery
               2015;10(6):e0129881.                               of mesenchymal stem cell secretome repairs the brain of
               doi: 10.1371/journal.pone.0129881                  Alzheimer’s mice. Cell Death Differ. 2021;28(1):203-218.
                                                                  doi: 10.1038/s41418-020-0592-2
            29.  Ma X,  Huang M, Zheng M, et al. ADSCs-derived extracellular
               vesicles alleviate neuronal damage, promote neurogenesis   41.  Shoma Suresh K, Bhat S, Guru BR, Muttigi MS, Seetharam
               and rescue memory loss in mice with Alzheimer’s disease.    RN. A nanocomposite hydrogel delivery system for
               J Control Release. 2020;327:688-702.               mesenchymal stromal cell secretome.  Stem Cell Res Ther.
               doi: 10.1016/j.jconrel.2020.09.019                 2020;11(1):1-14.
                                                                  doi: 10.1186/s13287-020-01712-9
            30.  Bora P, Majumdar AS. Adipose tissue-derived stromal
               vascular fraction in regenerative medicine: A brief review on   42.  Perini G, Rosenkranz A, Friggeri G, et al. Advanced usage of
               biology and translation. Stem Cell Res Ther. 2017;8(1):145.  Ti3C2Tx MXenes for photothermal therapy on different 3D
               doi: 10.1186/s13287-017-0598-y                     breast cancer models. Biomed Pharmacother. 2022; 153:113496.
                                                                  doi: 10.1016/j.biopha.2022.113496
            31.  Teixeira FG, Carvalho MM, Sousa N, Salgado AJ.
               Mesenchymal stem cells secretome: A new paradigm for   43.  Rosenkranz A, Perini G, Aguilar-Hurtado JY, et al. Laser-
               central nervous system  regeneration?  Cell Mol Life Sci.   mediated antibacterial effects of few- and multi-layer
               2013;70:3871-3882.                                 Ti3C2Tx MXenes. Appl Surf Sci. 2021;567:150795.
               doi: 10.1007/s00018-013-1290-8                     doi: 10.1016/j.apsusc.2021.150795
            32.  Drago D, Cossetti C, Iraci N, et al. The stem cell secretome and   44.  Perini G, Rosa E, Friggeri G, et al. INSIDIA 2.0 high-
               its role in brain repair. Biochimie. 2013;95(12):2271-2285.  throughput analysis of 3D cancer models: Multiparametric
               doi: 10.1016/j.biochi.2013.06.020                  quantification of graphene quantum dots photothermal
                                                                  therapy for glioblastoma and pancreatic cancer.
            33.  Ghasemi M, Roshandel E, Mohammadian M, et al.    Int J Mol Sci. 2022;23:3217.
               Mesenchymal stromal cell-derived secretome-based therapy      doi: 10.3390/ijms23063217
               for neurodegenerative diseases: Overview of clinical trials.
               Stem Cell Res Ther. 2023;14(1):1-20.            45.  Perini G, Palmieri V, Friggeri G, Augello A, De Spirito
               doi: 10.1186/s13287-023-03264-0                    M, Papi M. Carboxylated graphene quantum dots-


            Volume 10 Issue 1 (2024)                       240                          https://doi.org/10.36922/ijb.1045
   243   244   245   246   247   248   249   250   251   252   253